Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) — Long-term Investment Intensity
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has a Long-term Investment Intensity of 0.3% as of September 2019. Long-term investments of CN¥1.75 Million represent 0.3% of total assets of CN¥525.73 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 600671 financial resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 0.3%, reflecting long-term investments of CN¥1.75 Million against total assets of CN¥525.73 Million CNY. For the complete balance sheet picture, see balance sheet size of Hangzhou TianMuShan Pharmaceutical Enter.
Annual Long-term Investment Intensity for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Hangzhou TianMuShan Pharmaceutical Enter debt and liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.4% | CN¥1.75 Million | CN¥480.62 Million | ▼ 0.0 pp |
| 2017 | 0.4% | CN¥1.75 Million | CN¥450.44 Million | ▼ -2.7 pp |
| 2016 | 3.1% | CN¥9.35 Million | CN¥306.19 Million | ▼ -0.3 pp |
| 2015 | 3.3% | CN¥9.37 Million | CN¥280.38 Million | — |